# A Study Evaluating the Safety and Efficacy of Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres to Bridge or Downstage Patients With Hepatocellular Carcinoma (HCC) to Liver Transplant or Resection and Elicit Pathologic Necrosis.

> **NCT07663487** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sirtex Medical** · enrollment: 78 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **DEVICE:** SIR-Spheres Selectively Delivered to Liver Tumor

## Key facts

- **NCT ID:** NCT07663487
- **Lead sponsor:** Sirtex Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2029-10
- **Final completion:** 2029-10
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07663487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07663487, "A Study Evaluating the Safety and Efficacy of Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres to Bridge or Downstage Patients With Hepatocellular Carcinoma (HCC) to Liver Transplant or Resection and Elicit Pathologic Necrosis.". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT07663487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*